ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

IASLC Looks Back at 50 Years of Growth, Collaboration, and Progress in Lung Cancer

Fred Gebhart
on: September 24, 2024In: Meeting News, WCLC News
IASLC Looks Back at 50 Years of Growth, Collaboration, and Progress in Lung Cancer

A special plenary at WCLC 2024 recognized a half-century of advances in thoracic oncology while reflecting on how far the IASLC has come since its first meeting. Read more


Study Shows Patients at Lowest Risk May Benefit from Longer Intervals Between Lung Cancer Screening

Fred Gebhart
on: September 24, 2024In: Meeting News, Screening/ED, WCLC News
Study Shows Patients at Lowest Risk May Benefit from Longer Intervals Between Lung Cancer Screening

Dr. Annette McWilliams says the PanCan nodule management protocol demonstrates potential to streamline lung cancer screening and management processes. Read more

Analyzing the CheckMate Trials: How do Clinicians Choose the Winning Strategy for Patients With Resectable NSCLC?

Krithika Subramanian, PhD
on: September 24, 2024In: Meeting News, WCLC News
Analyzing the CheckMate Trials: How do Clinicians Choose the Winning Strategy for Patients With Resectable NSCLC?

During WCLC 2024, Dr. Patrick Forde presented data from the CheckMate 77T and CheckMate 816 trials that may help guide lung cancer management in the near future. Read more

Phase II FLOWERS Trial Unveils Potential New First-Line Therapy Option

Fred Gebhart
on: September 24, 2024In: Meeting News, WCLC News
Phase II FLOWERS Trial Unveils Potential New First-Line Therapy Option

Results from the study, presented by Dr. Jin-Ji Yang, suggest that a combination regimen of osimertinib plus savolitinib may be superior to osimertinib alone for EGFR-mutated NSCLC. Read more

Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology

Krithika Subramanian, PhD
on: September 10, 2024In: Meeting News, WCLC News
Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology

A novel computational pathology approach reveals the potential of TROP2 as a predictor of response to anti-TROP2 therapy in NSCLC. Read more

FURTHER Study Moves the Needle Farther on Targeted Therapy Directed at Atypical EGFR Mutations in NSCLC

Krithika Subramanian, PhD
on: September 10, 2024In: Meeting News, WCLC News
FURTHER Study Moves the Needle Farther on Targeted Therapy Directed at Atypical EGFR Mutations in NSCLC

Furmonertinib, an oral, brain-penetrant, mutation-selective EGFR TKI, demonstrates activity in patients with EGFR PACC mutations. Read more

Aumolertinib After CRT Significantly Improves PFS in EGFR-mutated Unresectable NSCLC

Fred Gebhart
on: September 10, 2024In: Meeting News, WCLC News
Aumolertinib After CRT Significantly Improves PFS in EGFR-mutated Unresectable NSCLC

The third-generation EGFR TKI joins osimertinib in demonstrating a meaningful progression-free survival benefit for consolidation following chemoradiation. Read more

Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy

Fred Gebhart
on: September 10, 2024In: Meeting News, WCLC News
Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy

Experts will focus on overcoming barriers in patient advocacy on a global basis and enhancing the patient-physician partnership. Read more

IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology

Erin Jungmeyer
on: September 09, 2024In: Meeting News, Society News, WCLC News
IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology

Tuesday morning, nine expert clinicians and researchers in the field will give award lectures in honor of their contributions to the treatment of lung cancer. Read more

Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey

Fred Gebhart
on: September 09, 2024In: Meeting News, Society News, WCLC News
Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey

Drs. Narjust Florez and Cecilia Pompili will co-chair the session, which will also include tips for improving inclusion in clinical trials, creating a mutually respective work environment, and more. Read more

«‹3456789›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy